3D Bioprinting in Medical Industry Market Size, Share, Trends, 2022 Growth Challenges and Opportunities, Industry Statistics, Progression Status, Emerging Demands, Future Trends, Share, Covid-19 Impact, Top Leading Players with Strategies and Forecast 2031

Kenneth Research recently added a report on ‘3D Bioprinting in Medical Industry Market’ in its database of market research reports which provides its readers an in-depth analysis on the latest trends, growth opportunities and growth drivers that are associated with the growth of the market. The report additionally shares critical insights on the COVID-19 impacts on the 3D Bioprinting in Medical Industry Market, along with the compound growth rate (CAGR) of the market for a projected period between 2022 and 2031. The report also includes analysis of the market by utilizing different analytical tools, such as PESTEL analysis and Porter’s five forces analysis. These tools also provide an in-depth analysis on the micro and macro-environmental factors that are associated with the growth of the market during the forecast period.

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for 3D Bioprinting in Medical Industry Market products.

Request of this Sample Report – https://www.kennethresearch.com/sample-request-10151874

“In 2021, the global 3D bioprinting market is estimated to be worth USD ~2 billion, and it is expected to grow at a compound annual growth rate (CAGR) of ~17% from 2022 to 2030. The growth of this market is attributed to the limited number of organ donors and an aging population suffering from chronic respiratory diseases. Increasing R&D investment, technological progress, and increasing incidence of chronic diseases are other important influencing attributes that may drive market growth during the forecast period. Fatigue and overloaded sanitation system.

Therefore, in response to the increase in coronavirus cases, various 3D bioprinting communities are responding to the global crisis by providing their own skills to reduce the burden on the supply chain and the government. , There has been a shortage of materials for medical professionals and the general public. One of the biggest problems is the inability to obtain COVID-19 test kits. Therefore, several 3D bioprinting companies are manufacturing 3D printers and related software on a large scale.​​​​ For example, Formlabs, a Massachusetts-based company, now produces 100,000 nasal swabs per day for COVID-19 testing. Due to the increase in COVID-19 cases, the demand for 3D bioprinters continues to increase, and the 3D bioprinting market is expected to grow exponentially.

The coronavirus pandemic has also accelerated the development of drug and vaccine testing, and how scientists can use new technology to test patients for safety after preclinical trials are completed. With the increase in COVID-19 cases, the medical community is also facing a shortage of ventilators and ventilators. 3D bioprinting technology is helping to make respirators and ventilators to overcome the shortage of these devices. Recently, 3D bioprinting company CLECELL used its proprietary U-FAB 3D printer and other bioprinting technologies to create respiratory epithelial models. Respiratory tract epithelium is a tissue distributed in most of the respiratory tract. This epithelial cell acts as a barrier against pathogens and foreign particles.However, it can also prevent infection and tissue damage with the help of a mucociliary lifter. Therefore, as the demand for this respiratory epithelial model continues to increase, the 3D bioprinting market is expected to grow. Due to these innovations, the market is expected to grow further during the forecast period. Many biotherapy companies are using 3D bioprinting technology to accelerate COVID-19 research. For example, Viscient Biosciences uses 3D bioprinting technology to create lung tissue, supports research on viral infectivity, and helps find effective treatments for SARS-CoV-2 (the new coronavirus that causes COVID-19).

The Wyss Institute at Harvard University, in collaboration with healthcare, industry partners, and other research institutions, designed a fully injection molded nasopharyngeal swab. With the increasing popularity of Covid-19, 3D bioprinting is experiencing large-scale demand. Therefore, many pharmaceutical and biopharmaceutical participants help medical staff, doctors, and scientists in every possible way. For example, Stratasys is one of the leading 3D printer manufacturers in the United States, which manufactures masks with the help of 3D bioprinters. As of March 2020, they have shipped 100,000 masks to the United States.

Technical insight: 

The inkjet-based part dominates the 3D bioprinting market and will occupy the largest revenue share of 35% in 2020, because it can use biotin and other biological materials to print complex living organs or tissues on the substrate. The widespread adoption of inkjet printing in the medical field has promoted the growth of this market segment.

This article introduces the research trend of inkjet printing as a bio-applicable technology, especially in the fields of tissue engineering and drug delivery systems. Due to increased demand and increased reliability, this market segment is expected to witness significant growth during the forecast period. During the forecast period, the maglev part is expected to grow at the fastest compound annual growth rate of 17.0%. The lucrative growth can be attributed to the profitability associated with the technology.

With its advanced functions, higher speed and accuracy, magnetic levitation technology is expected to solve more than 80.0% of errors in 3D bioprinting. These bioprinters are also used for toxicity testing, blood vessel muscle printing and human cell regeneration. For example, BioAssay has developed a tissue-like structure with the help of a device based on magnetic levitation. Due to the rapid increase in the use of newer technologies, magnetic levitation-based devices are more likely to experience slow growth during the forecast period.

Application type information : 

The medical sector dominates the 3D bioprinting market and will account for the largest revenue share in 2020 at 35%. The compound annual growth rate of this sector is expected to be 21% during the forecast period. The widespread use of pills to treat various chronic diseases is driving the growth of the bio 3D printing market.
In addition, the increasing demand for drugs and the profitable applications of biopharmaceuticals using this technology are further promoting the development of this market segment. With more and more participants in the pharmaceutical industry, the demand for pills is also increasing. Millions of people around the world regularly use medicinal capsules and pills.

Therefore, this market segment is expected to achieve lucrative growth during the forecast period. During the forecast period, the tissue and organ generation sub-segment is expected to witness the fastest compound annual growth rate of 18% in the 3D bioprinting market. 3D bioprinting is more widely used in regenerative medicine to meet the regeneration needs of organs and tissues suitable for transplantation.

As the incidence of COVID-19 disease increases, so does the demand for tissue and organ production. For this reason, it is expected that the tissue and organ production part will experience exponential growth during the forecast period. The increasing number of COVID -19 cases worldwide is expected to provide major market players with new growth avenues. Several players in the 3D bioprinting market are developing new technologies that can overcome this pandemic effect and produce a vaccine to treat COVID-19.

Access Full Report here – https://www.kennethresearch.com/report-details/3d-bioprinting-in-medical-industry-market/10151874

About Us
Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defense, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research, are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.

Contact Us
Name: Kenneth research
Phone: +1 313 462 0609

Leave a Reply